Case File
efta-02539417DOJ Data Set 11OtherEFTA02539417
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02539417
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Giuffrida, David J
Sent:
Monday, May 23, 2011 6:44 PM
To:
Epstein, Jeffrey ([email protected])
Cc:
Barrett, Paul S
Subject:
Trade details
Jeffrey,
You unwound your GS total return sw=ps (50,000 shares) @ an average price of 5135.754/share. </=:p>
Let me know =f you have any questions.
Thanks again.
David J. Giuffr=da
J.P. Morgan I Global Investment Opportunities Group=/span>
40 West 57th Street, Floor 33
New York, NY 10019=/p
T: 212-622-2972
F: 212-310-0108
IRS =ircular 230 Disclosure:
JPMorgan Chase &=Co. and its affiliates do not provide tax advice. Accordingly, a=y discussion of U.S. tax
matters contained he=ein (including any attachments) is not intended or written to be used, and=cannot be used, in
connection with the promotion, marketing or recommendat=on by anyone unaffiliated with JPMorgan Chase & Co. of
any of the ma=ters addressed herein or for the purpose of avoiding U.S. tax-related =enalties.
This is not an official confirmation=2E
EFTA_R1_01687829
EFTA02539417
<=0:p>
This communication is for informational pu=poses only. It is not intended as an offer or solicitation for the purch=se or
sale of any financial instrument or as an official confirmation of a=y transaction. All market prices, data and other
information are not war=anted as to completeness or accuracy and are subject to change without not=ce. Any
comments or statements made herein do not necessarily reflect th=se of JPMorgan Chase & Co., its subsidiaries and
affiliates. =OAThis transmission may contain information that is privileged, confidenti=l, legally privileged, and/or exempt
from disclosure under applicable law=2E If you are not the intended recipient, you are hereby notified that
any=disclosure, copying, distribution, or use of the information contained her=in (including any reliance thereon) is
STRICTLY PROHIBITED. Although thi= transmission and any attachments are believed to be free of any virus or =ther
defect that might affect any computer system into which it is receive= and opened, it is the responsibility of the
redpient to ensure that it i= virus free and no responsibility is accepted by JPMorgan Chase & Co., i=s subsidiaries and
affiliates, as applicable, for any loss or damage arisi=g in any way from its use. If you received this transmission in error,
p=ease immediately contact the sender and destroy the material in its entire=y, whether in electronic or hard copy
format. Thank you. Pl=ase refer to http://www.jpmorgan.com/pages/disdosures for disdosures=relating to European
legal entities.
2
EFTA_R1_0 1687830
EFTA02539418
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
212-310-0108Phone
212-622-2972Phone
2539417Phone
2539418URL
http://www.jpmorgan.com/pages/disdosuresRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.